Email updates

Keep up to date with the latest news and content from Malaria Journal and BioMed Central.

Open Access Research

Polymorphism and epitope sharing between the alleles of merozoite surface protein-1 of Plasmodium falciparum among Indian isolates

Anitha Mamillapalli13, Sujatha Sunil2, Suraksha S Diwan2, Surya K Sharma1, Prajesh K Tyagi1, Tridibes Adak1, Hema Joshi1 and Pawan Malhotra2*

Author Affiliations

1 Department of Parasitolgy, National Institute for Malaria Research, New Delhi, India

2 Malaria Group, Internationl Centre for Genetic Engineering and Biotechnology, New Delhi, India

3 presently working at Centre for Cellular and Molecular Biology, Hyderabad, India

For all author emails, please log on.

Malaria Journal 2007, 6:95  doi:10.1186/1475-2875-6-95

Published: 20 July 2007



The C-terminal region of merozoite surface protein-1 (MSP-1) is one of the leading candidates for vaccination against the erythrocytic stages of malaria. However, a major concern in the development of MSP-1 based malaria vaccine is the polymorphism observed in different geographical Plasmodium falciparum isolates. To explore whether the sequence heterogeneity of PfMSP-1 leads to variation in naturally acquired anti-MSP-119 antibodies, the present study was undertaken to study PfMSP-119 sequence polymorphism in malaria-endemic villages in eastern India and also carried out a competition enzyme-linked immunosorbent assay using three PfMSP-119 variant forms.


The sequence variations in the C-terminal region of PfMSP-119 were determined in a malaria endemic region. Three PfMSP-119 variants were produced in Escherichia coli (PfMSP119QKNG-L, PfMSP119EKNG-L and PfMSP119ETSR-F) and an immunodepletion assay was carried out using the corresponding patients' sera.


Results revealed predominance of PfMAD20 allele among Indian field isolates. Seven PfMSP-119 variant forms were isolated in a singe geographical location. Three of PfMSP-119 variant forms when expressed in E. coli showed presence of cross-reaction as well as variant specific antibodies in malaria infected patient sera.


The present study demonstrates the existence of allele specific antibodies in P. falciparum-infected patient sera, however their role in protection requires further investigation. These results thereby, suggest the importance of a multi-allelic PfMSP-119 based vaccine for an effective malaria control.